Cited by 336

The DOI matches its Crossref record.

A multicenter, placebo-controlled, randomized, double-blind, prospective trial of prophylactic ursodiol for the prevention of gallstone formation following gastric-bypass-induced rapid weight loss

Sugerman, Harvey J., Brewer, William H., Shiffman, Mitchell L., Brolin, Robert E., Fobi, Mathias A.L., Linner, John H., MacDonald, Kenneth G., MacGregor, Alex M., Martin, Louis F., Oram-Smith, Jeffrey C., Popoola, Dapo, Schirmer, Bruce D., Vickers, Florence F.·1995·The American Journal of Surgery

Abstract

Background Previous studies have documented a high incidence of gallstone formation following gastric-bypass (GBP)-induced rapid weight loss in morbidly obese patients. This study was designed to determine if a 6-month regimen of prophylactic ursodiol might prevent the development of gallstones. Methods A multicenter, randomized, double-blind, prospective trial evaluated 3 oral doses of ursodiol: 300, 600, and 1,200 mg versus placebo beginning within 10 days after surgery and continuing for 6 months or until gallstone development, for patients with a body mass index (BMI) > or = 40 kg/m2. All patients had normal intraoperative gallbladder sonography. Transabdominal sonography was obtained at 2, 4, and 6 months following surgery, or until gallstone formation. Results Of 233 patients with at least one postoperative sonogram, 56 were randomized to placebo, 53 to 300 mg ursodiol, 61 to 600 mg ursodiol, and 63 to 1,200 mg ursodiol. Preoperative age, sex, race, weight, BMI, and postoperative weight loss were not significantly different between groups. Gallstone formation occurred at 6 months in 32%, 13%, 2%, and 6% of the patients on the respective doses. Gallstones were significantly (P Conclusion A daily dose of 600 mg ursodiol is effective prophylaxis for gallstone formation following GBP-induced rapid weight loss.

Overview

Integrity signals

Registry

Crossref · 10.1016/s0002-9610(99)80115-9

Cites

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

No references could be resolved yet.

Research works printed but not linked: 26

  1. Wattchow, 1983, Prevalence and treatment of gall stones after gastric bypass surgery for morbid obesity, Lancet., 286, 763
  2. Amaral, 1985, Gallbladder disease in the morbidly obese, Am J Surg., 149, 551, 10.1016/S0002-9610(85)80055-6 · DOI · Paper page
  3. Deitel, 1987, Incidence of symptomatic gallstones after bariatric operations, Surg Gynec Obstet., 164, 549
  4. Shiffman, 1991, Gallstone formation after rapid weight loss. A prospective study in patients undergoing gastric bypass surgery for treatment of morbid obesity, Am J Gastroenterol., 86, 1000
  5. Shiffman, 1993, Gallstones in patients with morbid obesity. Relationship to body weight, weight loss and gallbladder bile cholesterol solubility, Int J Obesity., 17, 153
  6. Worobetz, 1993, The effect of ursodeoxycholic acid therapy on gallstone formation in the morbidly obese during rapid weight loss, Am J Gastroenterol., 88, 1705
  7. Liddle, 1989, Gallstone formation during weight reduction dieting, Arch Intern Med., 149, 1750, 10.1001/archinte.1989.00390080036009 · DOI · Paper page
  8. Thijs, 1992, Is gallstone disease caused by obesity or by dieting?, Am J Epidemiol, 135, 274, 10.1093/oxfordjournals.aje.a116281 · DOI
  9. Broomfield, 1988, Effects of ursodeoxycholic acid and aspirin on the formation of lithogenic bile and gallstones during the loss of weight, NEJM., 319, 1567, 10.1056/NEJM198812153192403 · DOI · Paper page
  10. Shiffman, 1992, Changes in gallbladder bile composition following gallstone formation and weight reduction, Gastroenterology., 103, 214, 10.1016/0016-5085(92)91115-K · DOI · Paper page
  11. Nilsell, 1983, Comparative effects of ursodeoxycholic acid. chenodeoxycholic acid on bile acid kinetics and biliary lipid secretion in humans. Evidence for different modes of action on bile acid synthesis, Gastroenterotogy., 85, 1248, 10.1016/S0016-5085(83)80003-1 · DOI
  12. Mazella, 1991, Comparative evaluation of chenodeoxycholic and ursodeoxycholic acids in obese patients, Gastroenterology., 101, 490, 10.1016/0016-5085(91)90029-K · DOI
  13. Sugerman, 1993, Gastric bypass, Surg Rounds., 16, 169
  14. Brolin, 1992, Long-limb gastric bypass in the superobese. A prospective randomized study, Ann Surg., 215, 387, 10.1097/00000658-199204000-00014 · DOI
  15. Shiffman, 1994, A multi-center, double-blind, placebo controlled trial of ursodeoxycholic acid (urso) for prevention of gallstone (GS) formation in obese patients during very low calorie (VLC) dietary induced weight reduction, Gastroenterology., 106, A982
  16. Sugerman, 1989, Weight loss with vertical banded gastroplasty and Roux-en-Y gastric bypass for morbid obesity with selective versus random assignment, Am J Surg., 157, 93, 10.1016/0002-9610(89)90427-3 · DOI
  17. Sugerman, 1992, Gastric bypass for treating severe obesity, Am J Clin Nutr., 55, 560S, 10.1093/ajcn/55.2.560s · DOI
  18. Portes, 1992, Surgical treatment of obesity and its effect on diabetes: 10-year follow-up, Am J Clin Nutr., 55, 582S, 10.1093/ajcn/55.2.582s · DOI
  19. Sugerman, 1992, Long-term effects of gastric surgery for treating respiratory insufficiency of obesity, Am J Clin Nutr., 55, 597S, 10.1093/ajcn/55.2.597s · DOI · Paper page
  20. Foley, 1992, Impact of gastric restrictive surgery on hypertension in the morbidly obese, Am J Surg., 163, 294, 10.1016/0002-9610(92)90005-C · DOI
  21. Amaral, 1987, Reversal of benign intracranial hypertension by surgically induced weight loss, Arch Surg., 122, 946, 10.1001/archsurg.1987.01400200096018 · DOI
  22. Deitel, 1987, Sex hormone changes accompanying loss of massive excess weight, Gastroenterol Clin North Am., 16, 511, 10.1016/S0889-8553(21)00316-2 · DOI
  23. Bump, 1992, Obesity lower urinary tract function in women. Effect of surgically induced weight loss, Am J Obstet Gynec., 167, 392, 10.1016/S0002-9378(11)91418-5 · DOI
  24. Kral, 1992, Assessment of quality of life before and after surgery for severe obesity, Am J Clin Nutr., 55, 611S, 10.1093/ajcn/55.2.611s · DOI
  25. NIH Conference, 1991, 115, 956
  26. NIH Conference, 1992, 116, 942

Cited by

Sorted by citations

Metadata

Authors
Sugerman, H. J., Brewer, W. H., Shiffman, M. L., Brolin, R. E., Fobi, M. A. L., Linner, J. H., MacDonald, K. G., MacGregor, A. M., Martin, L. F., Oram-Smith, J. C., Popoola, D., Schirmer, B. D., & Vickers, F. F.
Venue
The American Journal of Surgery
Publisher
Elsevier BV
Published
1995-01
Volume
169
Issue
1
Pages
91-97
ISSN
0002-9610
Cited by
336
References
0
Language
en

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review